This is an update of treatment from the 1999 Task Force report. Recommendations for treating pulmonary and extra pulmonary disease were made using the GRADE system.
Educational aims
The Webinar will provide specific details regarding the rationale to treat sarcoidosis. It will also provide specific details regarding a step-wise approach to therapy.
Format
45 minutes lecture with illustrative case presentations prepared by Paola Rottoli and Peter Korsten (Task Force panel members). Followed by 15 minute Q&A from the audience.
Topics
The webinar will discuss the medications currently used to treat sarcoidosis.
- It will review the literature to support specific recommendations.
- It will highlight those areas where more studies need to be done.
Learning outcomes
Following the webinar, participants will be able to:
- Determine which pulmonary sarcoidosis should be considered for therapy.
- Identify the risk/benefit for individual therapy.
- Develop an evidence based treatment plan for extra pulmonary sarcoidosis including neurologic, cardiac, and cutaneous disease.
- Discuss the approach to fatigue and small fibre neuropathy in sarcoidosis.
CME credit
This webinar is accredited by the European Board for Accreditation in Pneumology (EBAP) and awards 1 CME credit per 1-hour attendance. The CME credit will be granted upon attendance during the live webinar only (attendance of at least 60 minutes is required).
What is a webinar?
The webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.
This webinar comprises a 40-minute lecture followed by a 20-minute question-and-answer session. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
Login guidelines
More information will be communicated in due course.
- Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.
- Check Central European Summer Time.
- To achieve the best quality, we recommend stopping all other programmes and avoiding downloading anything from the internet during your connection to the lecture.
- Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.
Diseases / methods
- Interstitial lung diseases
Target audience
- Clinicians
- Trainees
- Researchers